Addiction Medicine: Closing the Gap between Science and Practice

(lu) #1

likely than those who did not exercise to have
relapsed.^313


Chronic Disease Management .........................................................................................


Although the reasons are not yet clear, some
individuals may experience one episode in
which their symptoms meet clinical diagnostic
criteria for addiction and be non-symptomatic
thereafter.^314 In many cases, however, addiction
manifests as a chronic disease--a persistent or
long-lasting illness--which requires ongoing
professional treatment and management.^315 This
may be due to a preexisting brain dysfunction or
to changes that occur in the brain in response to
repeated exposure to addictive substances which
increase the vulnerability of the individual to
relapse, even after cessation of substance use.^316


All chronic diseases--regardless of whether they
are genetically based, driven by biological or
environmental influences or originate from some
combination of these factors--require long term,
evidence-based medical management of the
disease by qualified health professionals and
may include pharmaceutical and/or psychosocial
therapies as indicated, to assure that patients
remain symptom free and that co-occurring
health conditions and the patient’s nutrition and
exercise requirements are addressed.^317


Chronic disease management can improve
patient functioning, suppress symptoms, prevent
the development of additional diseases or co-
occurring conditions and reduce relapse.^318


Relapse can result from a wide range of factors
including cravings and withdrawal symptoms;
interpersonal conflict, peer pressure and other
stressors; and the patient’s emotional state,
motivation level, self-efficacy and ability to
cope with high-risk situations.^319 Recent
research also points to individual differences in
brain structure as a risk factor for relapse:
patients in treatment for addiction involving
alcohol who had reduced volumes of gray
matter* in the regions of the brain associated



  • Gray matter volumes were measured via magnetic


resonance imaging (MRI). Gray matter is considered
a reliable indicator of neural count and functionality.


with impulse control and cognitive function
were more likely to relapse after a shorter period
of time than those with higher volumes of gray
matter in these brain regions.^320 Yet another
obvious but rarely considered factor that may
contribute to relapse risk is that the treatment the
patient received simply was inadequate, either in
terms of the type of intervention provided or the
length or intensity of the treatment.^321

Chronic disease management, as it applies to
addiction treatment and relapse prevention,
seeks to address and prevent those factors that
increase the likelihood of relapse by ensuring
that treatment delivery is effective and that
personal, psychological and environmental risk
factors for relapse are addressed and
mitigated.^322 Specifically, physicians
supervising addiction treatment should assess
the need for chronic disease management and
ensure continuing care.^323

Medically Supervised Disease Management .............................................................


Health care providers are optimally situated to
provide clinical disease management.^324
Following acute treatment, the disease
management process is critical to help maintain
health and prevent relapse.^325

Patients who have received acute treatment for
addiction may require maintenance medications
such as methadone, buprenorphine, naltrexone,
disulfiram or NRT to prevent relapse.^326 Since
many patients with addiction have co-occurring
health conditions that may complicate their
treatment or exacerbate the risk of relapse,
medical professionals should carefully supervise
and coordinate treatment for all conditions.^327
Medical professionals supervising patient care
also may perform toxicology screens to monitor
patients’ substance use following acute
treatment and modify clinical interventions
accordingly.^328

Medical professionals also should supervise the
psychosocial interventions that patients receive
following acute addiction treatment.
Psychosocial therapy often is a critical
component of relapse prevention.^329
Collaborating with other health professionals, as
Free download pdf